Publicaciones en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (29)

2024

  1. Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells

    Scientific Reports, Vol. 14, Núm. 1

  2. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas

    Cancers, Vol. 15, Núm. 12

  3. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Actions and attitudes on the immunized patients against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15

  2. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  3. COVID-19: Some unresolved issues

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434

  4. Lessons from COVID-19 for future disasters: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 444-454

  5. Monkeypox in humans: a new outbreak

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518

  6. Persistence and viability of SARS-CoV-2 in primary infection and reinfections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 1-6

2021

  1. Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease

    European Journal of Pharmacology, Vol. 895

  2. Expansion of CD4 T lymphocytes expressing interleukin 17 and tumor necrosis factor in patients with major depressive disorder

    Journal of Personalized Medicine, Vol. 11, Núm. 3

  3. New variants of SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428

  4. Post-covid syndrome: A reflection and opinion paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 4, pp. 269-279

2020

  1. El Ipss De Llenado Como Herramienta Predictiva De La Mejoría En La Calidad De Vida Aplicable En Intervenciones Terapéuticas

    Archivos Espanoles de Urologia, Vol. 73, Núm. 2, pp. 81-88

2019

  1. Abnormal Distribution and Function of Circulating Monocytes and Enhanced Bacterial Translocation in Major Depressive Disorder

    Frontiers in Psychiatry, Vol. 10

2018

  1. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: Possible involvement of different binding sites at the PPARγ receptor

    Journal of Neuroinflammation, Vol. 15, Núm. 1

  2. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2017

  1. Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile” [Pharmacol. Res. (2016) 110(2016) (205–215)] (S1043661816302080) (10.1016/j.phrs.2016.03.021)

    Pharmacological Research